advances in nuclear cardiology matthew schumaecker, md, facc, fasnc medical director, nuclear...
TRANSCRIPT
Advances in Nuclear Cardiology
Matthew Schumaecker, MD, FACC, FASNC
Medical Director, Nuclear Cardiology
Carilion Clinic Cardiology
Assistant Professor of MedicineVirginia Tech Carilion School of Medicine
Educational Objectives
• Review advances in nuclear cardiology in:• Novel radiopharmaceuticals• Advances in camera software and hardware• Molecular imaging
Very Brief History of Nuclear Cardiology
• 1958 Scintillation Camera: Hal Anger
• 1972 Thallium 201
• 1976 SPECT camera: Keys, Jaszczak
• 1984 Cardiac PET Rb-82
• 1996 Cardiolite® (sestamibi) approved
Current State
• Most nuclear cameras in use are the same technology from 1970’s
• Sestamibi has been on the market for over 17 years
• Thallium mostly gone • MRI has replaced MUGA as gold standard
for LVEF assessment• PET imaging only in large academic centers
PET
• Advantages of PET over SPECT• Higher energy resolution • Mandatory attenuation correction• Quantification of coronary blood flow
• Disadvantages of PET over SPECT• Camera is MUCH more expensive• Radioisotopes are very short-lived
SPECT vs PET
Tc99m
140 keVɣray
F18
E=mc2
511keVphoton
511keVphoton
e-
β+
18F-Flurpiridaz PET
• Half life of currently utilized cardiac PET perfusion agents:
Agent T1/2
N-13 132 seconds
O-15 148 seconds
Rb-82 75 seconds
18F-Flurpiridaz PET
• 18F Fludeoxyglucose has t1/2 of 110 minutes
BUT
• This is a viability agent, not a perfusion agent
18F-Flurpiridaz PET
Jamshid Maddahi, M.D., FACC, FASNC, and René R. S. Packard, M.D.
123I-BMIPP
• 99mTc can be used to evalulate chest pain at rest but only if patient is having pain at the time.
Cardiac Memory
• Myocytes preferentially metabolize FFA
• In ischemia millieu, switch to glycolysis
Cardiac Memory
• Substrate switch can last up to 24 hours
• If injected with 123I-BMIPP, SPECT images will show defect if patient has been ischemic within 24 hours
Dilsizian et al, Circ 2005;112:2169-2174
BMIPP Trial
J Am Coll Cardiol. 2010 Jul 20;56(4):290-9
123I-MIBG
• MIBG is a sympathetic neurotransmitter radionuclide analog
• Cardiac uptake of MIBG is assessed by heart/mediastinal ratio.
• Correlates to heart failure severity, pre-disposition to cardiac arrhythmias, and poor prognosis
123I-MIBG
• As CHF progresses, there is a reduction in the number of presynaptic neurons and the function of the norepinephrine terminal resulting in decreased uptake of mIBG.
• Therefore, lower H/M ratios confer a more negative prognosis
123I-MIBG
Yazaki et al. Cardiomyopathies Chap 11
123I-MIBG ADMIRE-HF Trial
Jacobson et al J Am Coll Cardiol. 2010;55(20):2212-2221
”Two-year event rate was 15% for H/M ≥1.60 and 37% for H/M <1.60”
123I-MIBG ADMIRE-HF Trial
Jacobson et al J Am Coll Cardiol. 2010;55(20):2212-2221
123I-MIBG
> $1000 per dose No reimbursement in US
SPECT/CT
Gaemperli et al, Journal Nuc Med May 2007; 5:696
FBP vs OSEM
• Filtered backprojection suppresses high-frequency image data thereby decreasing noise. This causes image blurring and subjects the image to ramp filter artifact
• Iterative reconstruction provides an estimated reconstruction volume and compares it to image. This occurs until images converge
Depth DependentResolution Loss
Depth DependentResolution Recovery
• Wide beam reconstruction suppresses noise and enhances signal-to-noise ratio by modeling the statistical characteristics the collimator detector response.
• Statistical filters using Gaussian and Poisson Fourier transforms allow the deeper voxels to appear as they were closer, thereby eliminating DDRL
Depth DependentResolution Recovery
Depth DependentResolution Recovery
Hardware: Optimized Detector Geometry
Hardware: Optimized Detector Geometry
Solid State Detectors
Attenutation Correction
Two ways to do AC:
Attenutation Correction
Prone Imaging
• Shifts the heart off the diaphragm and places breasts in different position.
• Not as valuable as attenuation correction
• BUT – added counts in prone imaging are always real
Molecular Imaging
• Two major targets:• Vulnerable Plaque• Cardiac remodeling
Potential Targets
• IL-6
• VCAM – 1
• LT B4
• Matrix metalloproteases
• Cathepsins
• Anti-myosin antibodies
• Beta receptors
• ACE receptors
Apoptosis
Nahrendorf M et al. Circ Cardiovasc Imaging 2009;2:56-70
Copyright © American Heart Association
Atherosclerosis imaging
Nahrendorf M et al. Circ Cardiovasc Imaging 2009;2:56-70
Copyright © American Heart Association